Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Healthtrust
Merck
QuintilesIMS
Fuji
Johnson and Johnson
Boehringer Ingelheim
US Department of Justice
Moodys

Generated: May 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 075405

« Back to Dashboard

NDA 075405 describes CLADRIBINE, which is a drug marketed by Fresenius Kabi Usa, Mylan Labs Ltd, and West-ward Pharms Int, and is included in three NDAs. It is available from two suppliers. Additional details are available on the CLADRIBINE profile page.

The generic ingredient in CLADRIBINE is cladribine. There are eight drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the cladribine profile page.
Summary for 075405
Tradename:CLADRIBINE
Applicant:West-ward Pharms Int
Ingredient:cladribine
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 075405

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength1MG/ML
Approval Date:Feb 28, 2000TE:APRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
UBS
Cipla
Covington
Medtronic
McKesson
Fuji
Baxter
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.